v3.26.1
Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Total revenues $ 45,240 $ 44,018 $ 180,460
Total cost of revenues 26,124 23,269 104,053
Gross profit 19,116 20,749 76,407
Research and development expenses 2,181 4,246 12,995
Selling and marketing expenses 4,753 4,510 18,455
General and administrative expenses 5,229 4,198 18,724
Other expenses
Operating income (loss) 6,953 7,795 26,233
Financial income 425 534 1,921
Income (expenses) in respect of currency exchange differences and derivatives instruments, net (261) 251 (1,171)
Financial Income (expense) in respect of contingent consideration and other long- term liabilities. (1,538) (1,775) (2,652)
Financial expenses (188) (192) (864)
Income before tax on income 5,391 6,613 23,467
Taxes on income (1,259) (2,649) (3,269)
Net Income (loss) 4,132 3,964 20,198
Other Comprehensive Income (loss):      
Amounts that will be or that have been reclassified to profit or loss when specific conditions are met  
Gain (loss) on cash flow hedges 90 (114) 1,069
Net amounts transferred to the statement of profit or loss for cash flow hedges (273) (54) (943)
Items that will not be reclassified to profit or loss in subsequent periods:      
Remeasurement gain (loss) from defined benefit plan (11) 8 21
Total comprehensive income (loss) $ 3,938 $ 3,804 $ 20,345
Earnings per share attributable to equity holders of the Company:      
Basic net earnings per share (in Dollars per share) $ 0.07 $ 0.07 $ 0.35
Diluted net earnings per share (in Dollars per share) $ 0.07 $ 0.07 $ 0.35
Proprietary Products      
Total revenues $ 36,227 $ 40,017 $ 156,206
Total cost of revenues 18,202 19,738 83,928
Distribution      
Total revenues 9,013 4,001 24,254
Total cost of revenues $ 7,922 $ 3,531 $ 20,125